Sandbox:Sara

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]

Immunhistochemical staining of dermatofibrosarcoma protuberans shows:
- Positive staining for:
  - CD34 (strong in 95%)
  - Vimentin
  - Focal actin
  - ApoD^[1]^[2]^[3]
  - bcl2
  - NKI-C3^[4]
  - CD99^[5]
  - Nestin
  - Tenascin
  - CD163
  - Factor XIIIa
  - CD10
- Negative staining for:
  - Factor XIIIa (usually)
  - Keratin
  - EMA
  - S100
  - HMB45
  - Desmin
  - CD117^[6]

↑ West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T; et al. (2004). "Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans". Am J Surg Pathol. 28 (8): 1063–9. PMID 15252314.
↑ Lisovsky M, Hoang MP, Dresser KA, Kapur P, Bhawan J, Mahalingam M (2008). "Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans". Mod Pathol. 21 (1): 31–8. doi:10.1038/modpathol.3800971. PMID 17885669.
↑ Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G (2010). "D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans". Mod Pathol. 23 (3): 434–8. doi:10.1038/modpathol.2009.176. PMID 20062007.
↑ Ma CK, Zarbo RJ, Gown AM (1992). "Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans". Am J Clin Pathol. 97 (4): 478–83. doi:10.1093/ajcp/97.4.478. PMID 1553911.
↑ Diwan AH, Skelton HG, Horenstein MG, Kelly DR, Barrett TL, Bussian AH; et al. (2008). "Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity". J Cutan Pathol. 35 (7): 647–50. doi:10.1111/j.1600-0560.2007.00872.x. PMID 18201229.
↑ Labonte S, Hanna W, Bandarchi-Chamkhaleh B (2007). "A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma". J Cutan Pathol. 34 (11): 857–60. doi:10.1111/j.1600-0560.2007.00731.x. PMID 17944726.

[pmid15252314-1] West RB, Harvell J, Linn SC, Liu CL, Prapong W, Hernandez-Boussard T; et al. (2004). "Apo D in soft tissue tumors: a novel marker for dermatofibrosarcoma protuberans". Am J Surg Pathol. 28 (8): 1063–9. PMID 15252314.

[pmid17885669-2] Lisovsky M, Hoang MP, Dresser KA, Kapur P, Bhawan J, Mahalingam M (2008). "Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans". Mod Pathol. 21 (1): 31–8. doi:10.1038/modpathol.3800971. PMID 17885669.

[pmid20062007-3] Bandarchi B, Ma L, Marginean C, Hafezi S, Zubovits J, Rasty G (2010). "D2-40, a novel immunohistochemical marker in differentiating dermatofibroma from dermatofibrosarcoma protuberans". Mod Pathol. 23 (3): 434–8. doi:10.1038/modpathol.2009.176. PMID 20062007.

[pmid1553911-4] Ma CK, Zarbo RJ, Gown AM (1992). "Immunohistochemical characterization of atypical fibroxanthoma and dermatofibrosarcoma protuberans". Am J Clin Pathol. 97 (4): 478–83. doi:10.1093/ajcp/97.4.478. PMID 1553911.

[pmid18201229-5] Diwan AH, Skelton HG, Horenstein MG, Kelly DR, Barrett TL, Bussian AH; et al. (2008). "Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity". J Cutan Pathol. 35 (7): 647–50. doi:10.1111/j.1600-0560.2007.00872.x. PMID 18201229.

[pmid17944726-6] Labonte S, Hanna W, Bandarchi-Chamkhaleh B (2007). "A study of CD117 expression in dermatofibrosarcoma protuberans and cellular dermatofibroma". J Cutan Pathol. 34 (11): 857–60. doi:10.1111/j.1600-0560.2007.00731.x. PMID 17944726.

[1]

[2]

[3]

[4]

[5]

[6]

Sandbox:Sara

Navigation menu